Plain-English translation of NCT04790240 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing whether medicinal herbs can help your body fight COVID-19 more effectively. The idea is that when COVID-19 infects the body, the immune system sometimes overreacts and causes dangerous inflammation that can damage organs — and that's actually what causes the most harm, not the virus itself. The medication is designed to calm this overreaction so your immune system can do its job properly without harming you.
Currently, no drug directly kills the COVID-19 virus, and vaccines alone haven't stopped new variants from spreading. This trial exists because doctors believe the real danger in COVID-19 comes from the body's immune system overreacting rather than from the virus alone, and this medication may help prevent that harmful overreaction.
You likely qualify if…
You likely don't qualify if…
You would take medicinal herbs as the main part of this study. Before you start, you'll need blood tests and lung imaging done. During the treatment, you'll take the herbs and have follow-up evaluations to check how your inflammation levels are changing and how well your immune system is responding. The study tracks three types of inflammation — upper and lower respiratory symptoms, fever, and chest-related symptoms — to see if the medication helps reduce them.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States